Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy
D Duan - Molecular Therapy, 2018 - cell.com
Duchenne muscular dystrophy (DMD) is a lethal muscle disease caused by dystrophin gene
mutation. Conceptually, replacing the mutated gene with a normal one would cure the …
mutation. Conceptually, replacing the mutated gene with a normal one would cure the …
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
JW McGreevy, CH Hakim… - Disease models & …, 2015 - journals.biologists.com
Duchenne muscular dystrophy (DMD) is a progressive muscle-wasting disorder. It is caused
by loss-of-function mutations in the dystrophin gene. Currently, there is no cure. A highly …
by loss-of-function mutations in the dystrophin gene. Currently, there is no cure. A highly …
[HTML][HTML] A five-repeat micro-dystrophin gene ameliorated dystrophic phenotype in the severe DBA/2J-mdx model of Duchenne muscular dystrophy
CH Hakim, NB Wasala, X Pan, K Kodippili… - … Therapy-Methods & …, 2017 - cell.com
Micro-dystrophins are highly promising candidates for treating Duchenne muscular
dystrophy, a lethal muscle disease caused by dystrophin deficiency. Here, we report robust …
dystrophy, a lethal muscle disease caused by dystrophin deficiency. Here, we report robust …
The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies
GB Banks, JS Chamberlain - Current topics in developmental biology, 2008 - Elsevier
Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy.
There is no effective treatment and patients typically die in approximately the third decade …
There is no effective treatment and patients typically die in approximately the third decade …
Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophy
TLE Van Westering, CA Betts, MJA Wood - Molecules, 2015 - mdpi.com
Duchenne muscular dystrophy (DMD) is a genetic muscle disorder caused by mutations in
the Dmd gene resulting in the loss of the protein dystrophin. Patients do not only experience …
the Dmd gene resulting in the loss of the protein dystrophin. Patients do not only experience …
Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy
JN Robinson-Hamm, CA Gersbach - Human genetics, 2016 - Springer
Duchenne muscular dystrophy is one of the most common inherited genetic diseases and is
caused by mutations to the DMD gene that encodes the dystrophin protein. Recent …
caused by mutations to the DMD gene that encodes the dystrophin protein. Recent …
Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers
N Jearawiriyapaisarn, HM Moulton… - Cardiovascular …, 2010 - academic.oup.com
Aims The cardiomyopathy found in Duchenne muscular dystrophy (DMD) is responsible for
death due to heart failure in∼ 30% of patients and additionally contributes to many DMD …
death due to heart failure in∼ 30% of patients and additionally contributes to many DMD …
The potential of adeno-associated viral vectors for gene delivery to muscle tissue
Introduction: Muscle-directed gene therapy is rapidly gaining attention primarily because
muscle is an easily accessible target tissue and is also associated with various severe …
muscle is an easily accessible target tissue and is also associated with various severe …
The multifaceted view of heart problem in Duchenne muscular dystrophy
U Florczyk-Soluch, K Polak, J Dulak - Cellular and Molecular Life Sciences, 2021 - Springer
Dystrophin is a large protein serving as local scaffolding repetitively bridging cytoskeleton
and the outside of striated muscle cell. As such dystrophin is a critical brick primarily in …
and the outside of striated muscle cell. As such dystrophin is a critical brick primarily in …
Persistent expression of FLAG-tagged micro dystrophin in nonhuman primates following intramuscular and vascular delivery
LR Rodino-Klapac, CL Montgomery, WG Bremer… - Molecular Therapy, 2010 - cell.com
Animal models for Duchenne muscular dystrophy (DMD) have species limitations related to
assessing function, immune response, and distribution of micro-or mini-dystrophins …
assessing function, immune response, and distribution of micro-or mini-dystrophins …